Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Apperley

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Annals of Internal Medicine|February 1, 1997
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow TransplantationT Duell, M T van Lint, P Ljungman, et al.
The New England Journal of Medicine|January 23, 1986
Bone marrow transplantation for patients with chronic myeloid leukemiaJ M Goldman, J F Apperley, L Jones, et al.
British Journal of Haematology|June 1, 1988
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effectJ F Apperley, F R Mauro, J M Goldman, et al.
Bone Marrow Transplantation|March 28, 2006
Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosisJ B Perz, A Rahemtulla, C Giles, et al.
Bone Marrow Transplantation|May 1, 1986
Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapseJ F Apperley, L Jones, G Hale, et al.
British Journal of Haematology|December 1, 1989
Slow evolution of chronic myeloid leukaemia relapsing after BMT with T-cell depleted donor marrowT P Hughes, K Economou, S Mackinnon, et al.
Experimental Hematology|June 1, 1990
Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donorsS Mackinnon, J M Hows, J M Goldman, et al.
Blood|July 13, 2000
Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remissionC Craddock, R M Szydlo, J P Klein, et al.
British Journal of Haematology|April 12, 2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)M Michallet, A Thiébaut, P Dreger, et al.
Blood|December 1, 1986
Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemiaJ M Hows, J L Yin, J Marsh, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Annals of Internal Medicine|February 1, 1997
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow TransplantationT Duell, M T van Lint, P Ljungman, et al.
The New England Journal of Medicine|January 23, 1986
Bone marrow transplantation for patients with chronic myeloid leukemiaJ M Goldman, J F Apperley, L Jones, et al.
British Journal of Haematology|June 1, 1988
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effectJ F Apperley, F R Mauro, J M Goldman, et al.
Bone Marrow Transplantation|March 28, 2006
Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosisJ B Perz, A Rahemtulla, C Giles, et al.
Bone Marrow Transplantation|May 1, 1986
Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapseJ F Apperley, L Jones, G Hale, et al.
British Journal of Haematology|December 1, 1989
Slow evolution of chronic myeloid leukaemia relapsing after BMT with T-cell depleted donor marrowT P Hughes, K Economou, S Mackinnon, et al.
Experimental Hematology|June 1, 1990
Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donorsS Mackinnon, J M Hows, J M Goldman, et al.
Blood|July 13, 2000
Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remissionC Craddock, R M Szydlo, J P Klein, et al.
British Journal of Haematology|April 12, 2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)M Michallet, A Thiébaut, P Dreger, et al.
Blood|December 1, 1986
Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemiaJ M Hows, J L Yin, J Marsh, et al.
Pageof 14